Keyword: Biotechnology

News

Proxygen and US Merck Collaborate on Molecular Glue Degraders

12.04.2023 -

Austrian biotech Proxygen has announced a multi-year collaboration and license agreement with US drugmaker Merck & Co to identify and develop molecular glue degraders...

News

Bachem Inks $531 Million Peptides Manufacturing Deal

08.03.2023 -

Bachem, a Swiss specialist developer and manufacturer of peptides and oligonucleotides, has signed another order worth more than 500 million Swiss francs – or $531...

News

Pfizer in Talks to Take Cancer Biotech Seagen

01.03.2023 -

Pfizer is in the early stage of talks to acquire Seagen (formerly Seattle Genetics), a US biotech focused on developing treatments for cancer, according to a report in...

News

Solvay Joins Genesis Consortium to Boost Biotech

23.02.2023 -

Solvay’s venture capital fund has joined the Genesis Consortium, a global alliance of venture capital firms and corporations that support startups leveraging...

News

New Biotech VC Vehicle Pledges Series A Funding Aid

22.02.2023 -

A new venture capital vehicle launched by a group of biotech entrepreneurs is designed to act as a seed investor as well as a drug discovery co-pilot for biotech startups...

News

Croda Acquires South Korean Biotech Firm

08.02.2023 -

UK specialty chemicals company Croda International has agreed to buy Solus Biotech, a South Korean company specializing in ceramide and phospholipid technologies and with...

News

German Merck Licenses Fusion Protein to PDS

10.01.2023 -

Germany‘s Merck has granted an exclusive license for the tumor-targeting IL-12 fusion protein currently known as M9241 to PDS Biotechnology Corporation, a US-based...

News

AstraZeneca Boosts Cancer Portfolio with Neogene Buy

01.12.2022 -

AstraZeneca has agreed to acquire Neogene Therapeutics, a clinical-stage biotechnology company focused on the discovery, development and manufacture of next-generation T...